查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553694

REBOA（復苏性主动脉内球囊阻断）市场规模、份额、趋势分析报告：按应用、地区和细分市场预测，2024-2030 年

Resuscitative Endovascular Balloon Occlusion Of The Aorta Market Size, Share & Trends Analysis Report By End-use (Cardiac Arrest, Aortic Occlusion, Tactical Combat Casualty Care), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

市场规模及趋势：

2023年全球REBOA（復苏性主动脉内球囊阻断）市场规模为958万美元，预计2024年至2030年复合年增长率为19.9%。

推动该市场发展的是影响临床实践成长和采用的几个关键因素。这些驱动因素包括创伤性伤害的日益普及、医疗技术的进步、对创伤治疗通讯协定的日益重视、医疗保健专业人员意识的提高以及政府的支持性倡议。所有这些因素在塑造市场格局和加强 REBOA 作为救生干预措施的利用方面都发挥着重要作用。

创伤发生率的上升，特别是道路事故、跌倒和暴力造成的创伤，是 REBOA（復苏性主动脉内球囊阻断）市场的关键驱动因素。创伤病例常常导致失血性休克，因此对有效復苏技术的需求正在迅速增加。 REBOA 提供了一种微创选项，可以在紧急情况下快速部署，使其成为创伤外科医生和紧急医疗服务的有吸引力的选择。 2024 年 6 月，世界卫生组织 (WHO) 报告称，无意创伤和暴力创伤都是造成创伤的重要原因，每年导致 440 万人死亡。遭受创伤，尤其是在儿童时期，会增加心理健康问题、药物滥用、慢性病和社会问题的风险。

医疗设备的技术进步显着提高了 REBOA 的有效性和安全性。改进的球囊设计、更好的导管系统和改进的成像技术等创新正在促进手术过程中更精确的放置和监测。这些进步不仅改善了患者的治疗效果，也鼓励医疗保健提供者采用 REBOA 作为创伤治疗的标准技术。 2024 年 6 月，总部位于犹他州的 Emergency Scientific 宣布在获得 FDA 510(k) 批准后首次使用其 Landmark REBOA 导管。此导管用于紧急出血处理时暂时闭塞大血管。标誌性导管旨在提高闭塞精度，同时最大限度地减少与传统方法相关的併发症。

医疗保健专业人员越来越认识到 REBOA 在治疗创伤性出血方面的益处。认识到这一点，我们正在製定专门的培训计划，以教育临床医生正确使用 REBOA。对教育的日益重视意味着更多的医疗保健提供者拥有有效执行这项挽救生命的程序所需的知识和技能。 2024 年 3 月，《急诊医学杂誌》发表了针对急诊医学 Ta 设计的新型 REBOA 培训课程的先驱性研究的详细资讯。这门最先进的课程旨在提高急诊部住院医师应用 REBOA 程序的能力和理解，并改善危及生命的情况下患者的治疗结果。

围绕医疗设备的法规环境越来越支持 REBOA 等创新解决方案。监管机构已经认识到快速介入技术在创伤护理中的重要性，并正在简化新设备的核准流程。这种支持态度将鼓励製造商投资研发，进一步推动市场成长。 2024年2月，Neurescue宣布在A轮资金筹措中筹集了727万美元。这项投资由伦敦投资公司 West Hill Capital主导。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 REBOA（復苏性主动脉内球囊阻断）市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • REBOA（復苏性主动脉内球囊阻断）市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 REBOA（復苏性主动脉内球囊阻断）市场：最终用途估计与趋势分析

  • 全球 REBOA（復苏性主动脉内球囊阻断）市场：最终用途仪表板
  • 全球REBOA（復苏性主动脉内球囊阻断）市场：最终用途变化分析
  • 按最终用途分類的收益
  • 心臟麻痹
  • 主动脉闭塞
  • 战术性战斗伤患护理

第五章 REBOA（復苏性主动脉内球囊阻断）市场：按应用、类型和最终用途的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
  • 欧洲
  • 亚太地区

第六章 竞争状况

  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Prytime Medical Devices, Inc
    • NEURESCUE
    • Emergency Scientific, LLC
    • Qx Medical
    • Front Line Medical Technologies
    • Reboa Medical As
Product Code: GVR-4-68040-433-0

Market Size & Trends:

The global resuscitative endovascular balloon occlusion of the aorta market size was valued at USD 9.58 million in 2023 and is projected to grow at a CAGR of 19.9% from 2024 to 2030. The market is driven by several key factors that influence its growth and adoption in clinical settings. These drivers include the increasing prevalence of traumatic injuries, advancements in medical technology, a growing emphasis on trauma care protocols, rising awareness among healthcare professionals, and supportive government initiatives. Each of these elements plays a crucial role in shaping the market landscape and enhancing the utilization of REBOA as a life-saving intervention.

The rising incidence of traumatic injuries, particularly those resulting from road accidents, falls, and violence, is a significant driver for the Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) market. As trauma cases often lead to hemorrhagic shock, the demand for effective resuscitation techniques has surged. REBOA provides a minimally invasive option that can be rapidly deployed in emergency situations, making it an attractive choice for trauma surgeons and emergency medical services. In June 2024, the World Health Organization reported that injuries, both unintentional and violence-related, significantly contribute to trauma, leading to 4.4 million deaths annually. Exposure to trauma, especially during childhood, can heighten the risk of mental health issues, substance abuse, chronic diseases, and social problems.

Technological advancements in medical devices have significantly enhanced the efficacy and safety of REBOA procedures. Innovations such as improved balloon designs, better catheter systems, and enhanced imaging technologies facilitate more precise placement and monitoring during procedures. These advancements not only improve patient outcomes but also encourage healthcare providers to adopt REBOA as a standard practice in trauma care. In June 2024, Emergency Scientific, a Utah-based firm, announced the first use of its Landmark REBOA catheter, following its FDA 510(k) clearance. This device is for temporary occlusion of large vessels in emergency hemorrhage control. The Landmark catheter is designed to enhance the precision of occlusion while minimizing complications associated with traditional methods.

There is an increasing awareness among healthcare professionals regarding the benefits of REBOA in managing traumatic hemorrhage. Alongside this awareness, specialized training programs are being developed to educate clinicians on the proper use of REBOA techniques. This growing emphasis on education ensures that more healthcare providers are equipped with the knowledge and skills necessary to implement this life-saving procedure effectively. In March 2024, an article was published in the Journal of Emergency Medicine detailing A Pilot Study on A Novel REBOA Training Curriculum designed for Emergency Medicine Residents. This cutting-edge curriculum was designed to advance the competencies and understanding of Emergency Medicine residents in applying the REBOA technique, with the aim of bettering patient outcomes in life-threatening scenarios.

The regulatory environment surrounding medical devices has become increasingly supportive of innovative solutions like REBOA. Regulatory bodies are recognizing the importance of rapid intervention techniques in trauma care and are streamlining approval processes for new devices. This supportive stance encourages manufacturers to invest in research and development, further propelling market growth. In February 2024, Neurescue announced that it raised USD 7.27 million in a Series A funding round. This investment was spearheaded by West Hill Capital, a London-based investment firm.

Global Resuscitative Endovascular Balloon Occlusion Of The Aorta Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global resuscitative endovascular balloon occlusion of the aorta market report based on end-use, and region:

  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Cardiac Arrest
  • Aortic Occlusion
  • Tactical Combat Casualty Care
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. End Use
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. End Use outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidence of trauma cases
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Growing awareness and training programs
      • 3.2.1.4. Military applications
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Cost considerations
      • 3.2.2.2. Regulatory challenges
  • 3.3. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Estimates & Trend Analysis

  • 4.1. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Dashboard
  • 4.2. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Movement Analysis
  • 4.3. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Estimates and Forecasts, by End Use, Revenue (USD Million)
  • 4.4. Cardiac Arrest
    • 4.4.1. Cardiac arrest market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Aortic Occlusion
    • 4.5.1. Aortic occlusion market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Tactical Combat Casualty Care
    • 4.6.1. Tactical combat casualty care market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: Regional Estimates & Trend Analysis by Application, Type, and End Use

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Vendor Landscape
    • 6.2.1. List of key distributors and channel partners
    • 6.2.2. Key customers
    • 6.2.3. Key company market share analysis, 2023
    • 6.2.4. Prytime Medical Devices, Inc
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. NEURESCUE
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Emergency Scientific, LLC
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Qx Medical
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Front Line Medical Technologies
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Reboa Medical As
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 4 U.S. resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Canada resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 6 Europe resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
  • Table 7 Europe resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 8 Germany resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 9 UK resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 10 France resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Italy resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Spain resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Asia Pacific resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
  • Table 14 Aisa Pacific resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 15 China resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Japan resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: market outlook
  • Fig. 9 Resuscitative endovascular balloon occlusion of the aorta (REBOA) competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market driver impact
  • Fig. 13 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market restraint impact
  • Fig. 14 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: End use movement analysis
  • Fig. 15 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: End use outlook and key takeaways
  • Fig. 16 Cardiac arrest market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Aortic occlusion market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Tactical combat casualty care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market: Regional movement analysis
  • Fig. 20 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market: Regional outlook and key takeaways
  • Fig. 21 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market share and leading players
  • Fig. 22 North America, by country
  • Fig. 23 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. key country dynamics
  • Fig. 25 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Canada key country dynamics
  • Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 UK key country dynamics
  • Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Germany key country dynamics
  • Fig. 32 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 France key country dynamics
  • Fig. 34 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Italy key country dynamics
  • Fig. 36 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Spain key country dynamics
  • Fig. 38 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 China key country dynamics
  • Fig. 41 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Japan key country dynamics
  • Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)